Personal information

Verified email addresses

Tissue pathology, breast cancer, digital image analysis, computational pathology

Activities

Employment (4)

Vilnius University, Faculty of Medicine, Translational Health Research Institute, Center for Digital Medicine: Vilnius, LT

2024 to present | Senior researcher
Employment
Source: Self-asserted source
Dovile Zilenaite-Petrulaitiene

Vilnius University, Faculty of Medicine, Department of Pathology, Forensic Medicine and Pharmacology, Institute of Biomedical Sciences: Vilnius, LT

2023 to present | Associate Professor
Employment
Source: Self-asserted source
Dovile Zilenaite-Petrulaitiene

National Center of Pathology, an affiliate of Vilnius University Hospital Santaros Klinikos: Vilnius, N/A, LT

2021 to present | Biobank coordinator
Employment
Source: Self-asserted source
Dovile Zilenaite-Petrulaitiene

National Center of Pathology, an affiliate of Vilnius University Hospital Santaros Klinikos: Vilnius, LT

2015 to 2023 | Medical geneticist
Employment
Source: Self-asserted source
Dovile Zilenaite-Petrulaitiene

Education and qualifications (3)

Vilnius University: Vilnius, N/A, LT

2015-09-01 to 2021-05-20 | Doctoral degree (PhD, Medicine and Health Sciences, Medicine) (Faculty of Medicine, Department of Pathology, Forensic Medicine and Pharmacology, Institute of Biomedical Sciences)
Education
Source: Self-asserted source
Dovile Zilenaite-Petrulaitiene

Vilnius University: Vilnius, N/A, LT

2013-09-01 to 2015-06-17 | Master's degree (Medical Genetics, cum laude) (Vilnius University, Faculty of Medicine, Department of Human and Medical Genetics)
Education
Source: Self-asserted source
Dovile Zilenaite-Petrulaitiene

Vilnius University: Vilnius, N/A, LT

2009-09-01 to 2013-06-30 | Bachelor's degree (Biochemistry) (Vilnius University, Faculty of Chemistry and Geosciences)
Education
Source: Self-asserted source
Dovile Zilenaite-Petrulaitiene

Works (12)

Spatial distributions of CD8 and Ki67 cells in the tumor microenvironment independently predict breast cancer-specific survival in patients with ER+HER2– and triple-negative breast carcinoma

PLOS ONE
2024-11-22 | Journal article
Contributors: Dovile Zilenaite-Petrulaitiene; Pirkko L. Härkönen; Allan Rasmusson; Ruta Barbora Valkiuniene; Aida Laurinaviciene; Linas Petkevicius; Arvydas Laurinavicius
Source: check_circle
Crossref

Formalin-fixed paraffin-embedded sample sectioning and immunohistochemistry staining for ER, PR, Ki67, HER2, and CD8 at the National Centre of Pathology, affiliate of Vilnius University Hospital Santaros Klinikos (Vilnius, Lithuania) v1

2024-10-18 | Preprint
Contributors: Aida Laurinavieciene; Dovile Zilenaite-Petrulaitiene
Source: check_circle
Crossref

Low CD8+ Density Variation and R1 Surgical Margin as Independent Predictors of Early Post-Resection Recurrence in HCC Patients Meeting Milan Criteria

Current Oncology
2024-09-10 | Journal article
Contributors: Rokas Stulpinas; Ieva Jakiunaite; Agne Sidabraite; Allan Rasmusson; Dovile Zilenaite-Petrulaitiene; Kestutis Strupas; Arvydas Laurinavicius; Aiste Gulla
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Overall Survival Prediction by Tumor Microenvironment Lymphocyte Distribution in Hepatocellular Carcinoma After Liver Transplantation

Journal of Surgical Research
2024-03 | Journal article
Part of ISSN: 0022-4804
Contributors: Aiste Gulla; Rokas Stulpinas; Agne Grigonyte; Dovile Zilenaite-Petrulaitiene; Allan Rasmusson; Arvydas Laurinavicius; Kestutis Strupas
Source: Self-asserted source
Dovile Zilenaite-Petrulaitiene

Intratumoral heterogeneity of Ki67 proliferation index outperforms conventional immunohistochemistry prognostic factors in estrogen receptor-positive HER2-negative breast cancer

Virchows Archiv
2024-01-13 | Journal article
Contributors: Dovile Zilenaite-Petrulaitiene; Allan Rasmusson; Justinas Besusparis; Ruta Barbora Valkiuniene; Renaldas Augulis; Aida Laurinaviciene; Benoit Plancoulaine; Linas Petkevicius; Arvydas Laurinavicius
Source: check_circle
Crossref

Computational tissue immune response indicators to predict overall survival in hepatocellular carcinoma

European Journal of Surgical Oncology
2023-02 | Journal article
Part of ISSN: 0748-7983
Contributors: Rokas Stulpinas; Dovile Zilenaite-Petrulaitiene; Allan Rasmusson; Agne Grigonyte; Aiste Kielaite-Gulla; Kestutis Strupas; Arvydas Laurinavicius
Source: Self-asserted source
Dovile Zilenaite-Petrulaitiene

Prognostic Value of CD8+ Lymphocytes in Hepatocellular Carcinoma and Perineoplastic Parenchyma Assessed by Interface Density Profiles in Liver Resection Samples

Cancers
2023-01-05 | Journal article
Contributors: Rokas Stulpinas; Dovile Zilenaite-Petrulaitiene; Allan Rasmusson; Aiste Gulla; Agne Grigonyte; Kestutis Strupas; Arvydas Laurinavicius
Source: check_circle
Crossref

Imunohistocheminių biožymenų tyrimai hormonų receptorių teigiamos duktalinės krūties karcinomos mikroaplinkos erdviniame kontekste skaitmeninės vaizdo analizės metodu

2021 | Dissertation or Thesis
Source: check_circle
Crossref

Intratumoral Heterogeneity and Immune Response Indicators to Predict Overall Survival in a Retrospective Study of HER2-Borderline (IHC 2+) Breast Cancer Patients

Frontiers in Oncology
2021 | Journal article
EID:

2-s2.0-85120427027

Part of ISSN: 2234943X
Contributors: Radziuviene, G.; Rasmusson, A.; Augulis, R.; Grineviciute, R.B.; Zilenaite, D.; Laurinaviciene, A.; Ostapenko, V.; Laurinavicius, A.
Source: Self-asserted source
Dovile Zilenaite-Petrulaitiene via Scopus - Elsevier

Tumor collagen framework from bright-field histology images predicts overall survival of breast carcinoma patients

Scientific Reports
2021 | Journal article
EID:

2-s2.0-85111496797

Part of ISSN: 20452322
Contributors: Morkunas, M.; Zilenaite, D.; Laurinaviciene, A.; Treigys, P.; Laurinavicius, A.
Source: Self-asserted source
Dovile Zilenaite-Petrulaitiene via Scopus - Elsevier

Independent Prognostic Value of Intratumoral Heterogeneity and Immune Response Features by Automated Digital Immunohistochemistry Analysis in Early Hormone Receptor-Positive Breast Carcinoma.

Frontiers in oncology
2020-06 | Journal article
Contributors: Zilenaite D; Rasmusson A; Augulis R; Besusparis J; Laurinaviciene A; Plancoulaine B; Ostapenko V; Laurinavicius A
Source: Self-asserted source
Dovile Zilenaite-Petrulaitiene via Europe PubMed Central
grade
Preferred source (of 2)‎

Immunogradient Indicators for Antitumor Response Assessment by Automated Tumor-Stroma Interface Zone Detection.

The American journal of pathology
2020-03 | Journal article
Contributors: Rasmusson A; Zilenaite D; Nestarenkaite A; Augulis R; Laurinaviciene A; Ostapenko V; Poskus T; Laurinavicius A
Source: Self-asserted source
Dovile Zilenaite-Petrulaitiene via Europe PubMed Central
grade
Preferred source (of 2)‎